Clinical tool — for healthcare professionals. This interpreter provides general guidance only. NT-proBNP and BNP must be interpreted in clinical context. Elevated levels do not confirm heart failure — further investigation is needed. Your clinical judgement applies.

NT-proBNP reference thresholds

Setting Heart failure unlikely Grey zone Heart failure likely
Acute (any age)<300300–450 / 900 / 1,800*>450 (<50y) / >900 (50-75y) / >1,800 (75+)
Non-acute (GP)<125125–450>450 (or >125 if <75y)

*Acute age-stratified thresholds per ESC 2021 guidelines. All values in pg/mL (= ng/L). Some labs report in pmol/L — divide by 0.118 to convert to pg/mL.

BNP reference thresholds

Setting Heart failure unlikely Heart failure likely
Acute<100>400
Non-acute (GP)<35>100

What can affect the result?

⬆️ Falsely elevated

Atrial fibrillation

Chronic kidney disease (eGFR <60)

Pulmonary embolism

Pulmonary hypertension

Sepsis / critical illness

Advancing age

Anaemia

⬇️ Falsely low

Obesity (BMI >35)

Flash pulmonary oedema (tested too early)

Constrictive pericarditis

End-stage cardiomyopathy (burned out)

Stable treated heart failure (on optimal therapy)

1. Echocardiogram — the next step for any elevated NT-proBNP. This confirms or excludes structural heart disease and measures ejection fraction (EF). Refer for transthoracic echo.

2. ECG — if not already done. A completely normal ECG makes heart failure very unlikely (negative predictive value >98%).

3. Bloods — FBC, UEC (renal function), LFTs, TFTs, iron studies, HbA1c, lipids. Looking for causes and comorbidities.

4. Chest X-ray — if acute symptoms. Look for cardiomegaly, pulmonary congestion, pleural effusions.

5. Consider referral — to cardiology if echo confirms reduced EF, or if diagnostic uncertainty. Urgent referral if severe symptoms (NYHA III-IV).

Most Australian pathology labs report NT-proBNP. It has a longer half-life and is less affected by acute haemodynamic changes. Either is acceptable for ruling out heart failure — but check which one your lab offers and use the correct reference range. The two tests are not interchangeable — their numbers are very different.

Medicare (MBS) rebates for BNP / NT-proBNP

There are four MBS pathology items for BNP or NT-proBNP. Which one applies depends on the clinical setting and the patient’s condition. Choose a setting:

Request and billing notes
  • Pathology providers advise stating the setting (for 66829, that the patient is seen in a non-hospital setting) and the clinical reasons in the clinical notes of the request so it can be checked against the criteria (Douglass Hanly Moir; Clinical Labs).
  • Clinical Labs states the test can still be requested when the criteria are not met or the frequency limit is exceeded, but the patient is then invoiced.
  • Items 66585 and 66586: if requested by a medical practitioner who is not a specialist or consultant physician, the MBS notes say the request should be made in consultation with the specialist or consultant physician managing the patient’s treatment.
  • All four items list the same schedule fee and benefits (MBS Book, July 2026). Fees and rules change; check the linked MBS Online item for the current descriptor before relying on them.

Source: Medicare Benefits Schedule (MBS Book, July 2026 edition), Category 6 Group P2, items 66829, 66830, 66585, 66586 — MBS Online item pages linked; explanatory notes PN.2.5 and PN.2.6 and rule 25(g) as printed in the Book. General information for clinicians, not clinical or legal advice; MBS rules and fees change.

You might also like